B6eGFPChAT mice overexpressing the vesicular acetylcholine transporter exhibit spontaneous hypoactivity and enhanced exploration in novel environments

Brain and Behavior

Volumn 3, Issue 4, 2013, Pages 367-383

  Nagy, Paul M ^a,b   Aubert, Isabelle ^a,b  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Choline acetyltransferase; Cholinergic; eGFP ChAT; Exploration; Locomotion; VAChT

Indexed keywords

VESICULAR ACETYLCHOLINE TRANSPORTER;

ADAPTIVE BEHAVIOR; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; EVOKED RESPONSE; EXPLORATORY BEHAVIOR; GENE DOSAGE; GENE OVEREXPRESSION; HABITUATION; LIGHT DARK CYCLE; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLEEP WAKING CYCLE; VESICULAR ACETYLCHOLINE TRANSPORTER GENE;

EID: 84893470167     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.139     Document Type: Article

References (74)

1. Ade, K. K., Y. Wan, M. Chen, B. Gloss, and N. Calakos. 2011. An improved BAC transgenic fluorescent reporter line for sensitive and specific identification of striatonigral medium spiny neurons. Front. Syst. Neurosci. 5:32.
2. Bazalakova, M. H., J. Wright, E. J. Schneble, M. P. McDonald, C. J. Heilman, A. I. Levey, et al. 2007. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav. 6:411-424.
3. Bedrosian, T. A., K. L. Herring, Z. M. Weil, and R. J. Nelson. 2011. Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice. Proc. Natl. Acad. Sci. 108:11686-11691.
4. Bell, K. F. S., and A. C. Cuello. 2006. Altered synaptic function in Alzheimer's disease. Eur. J. Pharmacol. 545:11-21.
5. Blusztajn, J. K., and R. J. Wurtman. 1983. Choline and cholinergic neurons. Science 221:614-620.
6. Bohnen, N. I., and R. L. Albin. 2011. The cholinergic system and Parkinson disease. Behav. Brain Res. 221:564-573.
7. Bolivar, V., and L. Flaherty. 2003. A region on chromosome 15 controls intersession habituation in mice. J. Neurosci. 23:9435-9438.
8. Bolivar, V. J., B. J. Caldarone, A. A. Reilly, and L. Flaherty. 2000. Habituation of activity in an open field: a survey of inbred strains and F1 hybrids. Behav. Genet. 30:285-293.
9. Brandon, E. P., T. Mellott, D. P. Pizzo, N. Coufal, K. A. D'Amour, K. Gobeske, et al. 2004. Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency. J. Neurosci. 24:5459-5466.
10. de Castro, B. M., X. De Jaeger, C. Martins-Silva, R. D. F. Lima, E. Amaral, C. Menezes, et al. 2009a. The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol. Cell. Biol. 29:5238-5250.
11. de Castro, B. M., G. S. Pereira, V. Magalhães, J. I. Rossato, X. De Jaeger, C. Martins-Silva, et al. 2009b. Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav. 8:23-35.
12. Chen, K. H., E. A. Reese, H. W. Kim, S. I. Rapoport, and J. S. Rao. 2011. Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J. Alzheimers Dis. 26:755-766.
13. Cohen, B. N., E. D. W. Mackey, S. R. Grady, S. McKinney, N. E. Patzlaff, C. R. Wageman, et al. 2012. Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior. Neuroscience 200:31-41.
14. Crawley, J. N. 2007. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. John Wiley & Sons., Inc., Hobolken, NJ.
15. Day, J., G. Damsma, and H. C. Fibiger. 1991. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 38:723-729.
16. Di Chiara, G., M. Morelli, and S. Consolo. 1994. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17:228-233.
17. Drenan, R. M., S. R. Grady, P. Whiteaker, T. McClure-Begley, S. McKinney, J. M. Miwa, et al. 2008. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity α6* nicotinic acetylcholine receptors. Neuron 60:123-136.
18. Drenan, R. M., S. R. Grady, A. D. Steele, S. McKinney, N. E. Patzlaff, J. M. McIntosh, et al. 2010. Cholinergic modulation of locomotion and striatal dopamine release is mediated by α6β4* nicotinic acetylcholine receptors. J. Neurosci. 30:9877-9889.
19. Dudar, J. D., I. Q. Whishaw, and J. C. Szerb. 1979. Release of acetylcholine from the hippocampus of freely moving rats during sensory stimulation and running. Neuropharmacology 18:673-678.
20. Efange, S. M. N., E. M. Garland, J. K. Staley, A. B. Khare, and D. C. Mash. 1997. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol. Aging 18:407-413.
21. Eiden, L. E. 1998. The cholinergic gene locus. J. Neurochem. 70:2227-2240.
22. File, S. E., L. E. Gonzalez, and N. Andrews. 1998. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic receptors. Behav. Neurosci. 112:352-359.
23. File, S. E., S. Cheeta, and P. J. Kenny. 2000. Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur. J. Pharmacol. 393:231-236.
24. Giovannini, M. G., A. Rakovska, R. S. Benton, M. Pazzagli, L. Bianchi, and G. Pepeu. 2001. Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience 106:43-53.
25. Giros, B., M. Jaber, S. R. Jones, R. M. Wightman, and M. G. Caron. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
26. Gomeza, J., L. Zhang, E. Kostenis, C. Felder, F. Bymaster, J. Brodkin, et al. 1999. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. 96:10483-10488.
27. Gotti, C., and F. Clementi. 2004. Neuronal nicotinic receptors: from structure to pathology. Prog. Neurobiol. 74:363-396.
28. Guzman, M. S., X. De Jaeger, S. Raulic, I. A. Souza, A. X. Li, S. Schmid, et al. 2011. Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behavior by cholinergic-glutamatergic co-transmission. PLoS Biol. 9:e1001194.
29. Kobayashi, K., S. Morita, H. Sawada, T. Mizuguchi, K. Yamada, I. Nagatsu, et al. 1995. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J. Biol. Chem. 270:27235-27243.
30. Krasteva, G., B. J. Canning, P. Hartmann, T. Z. Veres, T. Papadakis, C. Mühlfeld, et al. 2011. Cholinergic chemosensory cells in the trachea regulate breathing. Proc. Natl. Acad. Sci. 108:9478-9483.
31. Kuhl, D. E., S. Minoshima, J. A. Fessler, K. A. Frey, N. L. Foster, E. P. Ficaro, et al. 1996. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 40:399-410.
32. Labarca, C., J. Schwarz, P. Deshpande, S. Schwarz, M. W. Nowak, C. Fonck, et al. 2001. Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc. Natl. Acad. Sci. 98:2786-2791.
33. Lester, D. B., T. D. Rogers, and C. D. Blaha. 2010. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Ther. 16:137-162.
34. Liu, C., and M. U. Gillette. 1996. Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. J. Neurosci. 16:744-751.
35. Lund, D., A. M. Ruggiero, S. M. Ferguson, J. Wright, B. A. English, P. A. Reisz, et al. 2010. Motor neuron-specific overexpression of the presynaptic choline transporter: impact on motor endurance and evoked muscle activity. Neuroscience 171:1041-1053.
36. Martins-Silva, C., X. De Jaeger, M. S. Guzman, R. D. F. Lima, M. S. Santos, C. Kushmerick, et al. 2011. Novel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior. PLoS One 6:e17611.
37. Martyn, A. C., X. De Jager, A. C. Magalhaes, R. Kesarwani, D. F. Goncalves, S. Raulic, et al. 2012. Elimination of the vesicular acetylcholine transporter in the forebrain causes hyperactivity and deficits in spatial memory and long-term potentiation. Proc. Natl. Acad. Sci. 109:17651-17656.
38. McGranahan, T. M., N. E. Patzlaff, S. R. Grady, S. F. Heinemann, and T. K. Booker. 2011. α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J. Neurosci. 31:10891-10902.
39. McGuinness, B., S. L. Barrett, D. Craig, J. Lawson, and A. P. Passmore. 2010. Attention deficits in Alzheimer's disease and vascular dementia. J. Neurol. Neurosurg. Psychiatry 81:157-159.
40. Mega, M. S., D. M. Mastennan, S. M. O'Connor, T. R. Barclay, and J. L. Cummings. 1999. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch. Neurol. 56:1388-1393.
41. Misgeld, T., R. W. Burgess, R. M. Lewis, J. M. Cunningham, J. W. Lichtman, and J. R. Sanes. 2002. Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 36:635-648.
42. Mizuno, T., Y. Endo, J. Arita, and F. Kimura. 1991. Acetylcholine release in the rat hippocampus as measured by the microdialysis method correlates with motor activity and exhibits a diurnal variation. Neuroscience 44:607-612.
43. Nagy, P. M., and I. Aubert. 2012. Overexpression of the vesicular acetylcholine transporter increased acetylcholine release in the hippocampus. Neuroscience 218:1-11.
44. Ognibene, E., S. Middei, S. Daniele, W. Adriani, O. Ghirardi, A. Caprioli, et al. 2005. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav. Brain Res. 156:225-232.
45. Ogura, T., S. A. Szebenyi, K. Krosnowski, A. Sathyanesan, J. Jackson, and W. Lin. 2011. Cholinergic microvillous cells in the mouse main olfactory epithelium and effect of acetylcholine on olfactory sensory neurons and supporting cells. J. Neurophysiol. 106:1274-1287.
46. Pack, A. I., R. J. Galante, G. Maislin, J. Cater, D. Metaxas, S. Lu, et al. 2007. Novel method for high-throughput phenotyping of sleep in mice. Physiol. Genomics 28:232-238.
47. Parsons, S. M. 2000. Transport mechanisms in acetylcholine and monoamine storage. FASEB J. 14:2423-2434.
48. Piccininni, M., A. D. Carlo, M. Baldereschi, G. Zaccara, and D. Inzitari. 2005. Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease. Dement. Geriatr. Cogn. 19:276-281.
49. Picciotto, M. R., B. J. Caldarone, S. L. King, and V. Zachariou. 2000. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 22:451-465.
50. Prado, M. A. M., R. A. M. Reis, V. F. Prado, M. C. De Mello, M. V. Gomez, and F. G. De Mello. 2002. Regulation of acetylcholine synthesis and storage. Neurochem. Int. 41:291-299.
51. Prado, V. F., C. Martins-Silva, B. M. de Castro, R. F. Lima, D. M. Barros, E. Amaral, et al. 2006. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51:601-612.
52. Ribeiro, F. M., S. A. G. Black, V. F. Prado, R. J. Rylett, S. S. G. Ferguson, and M. A. M. Prado. 2006. The "ins" and "outs" of the high-affinity choline transporter CHT1. J. Neurochem. 97:1-12.
53. Rice, M. E., and S. J. Cragg. 2004. Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7:583-584.
54. Rizzoli, S. O., and W. J. Betz. 2005. Synaptic vesicle pools. Nat. Rev. Neurosci. 6:57-69.
55. Rosas-Ballina, M., P. S. Olofsson, M. Ochani, S. I. Valdés-Ferrer, Y. A. Levine, C. Reardon, et al. 2011. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334:98-101.
56. Salas, R., F. Pieri, B. Fung, J. A. Dani, and M. De Biasi. 2003. Altered anxiety-related responses in mutant mice lacking the β4 subunit of the nicotinic receptor. J. Neurosci. 23:6255-6263.
57. Sarter, M., and J. P. Bruno. 1999. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95:933-952.
58. Sarter, M., and V. Parikh. 2005. Choline transporters, cholinergic transmission and cognition. Nat. Rev. Neurosci. 6:48-56.
59. Schildein, S., J. P. Huston, and R. K. W. Schwarting. 2000. Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field. Neurobiol. Learn. Mem. 73:21-30.
60. Schildein, S., J. P. Huston, and R. K. W. Schwarting. 2002. Open field habituation learning is improved by nicotine and attenuated by mecamylamine administered posttrial into the nucleus accumbens. Neurobiol. Learn. Mem. 77:277-290.
61. Sterniczuk, R., M. C. Antle, F. M. LaFerla, and R. H. Dyck. 2010a. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes. Brain Res. 1348:149-155.
62. Sterniczuk, R., R. H. Dyck, F. M. LaFerla, and M. C. Antle. 2010b. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Res. 1348:139-148.
63. Tallini, Y. N., B. Shui, K. S. Greene, K. Y. Deng, R. Doran, P. J. Fisher, et al. 2006. BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons. Physiol. Genomics 27:391-397.
64. Thiel, C. M., J. P. Huston, and R. K. W. Schwarting. 1998. Hippocampal acetylcholine and habituation learning. Neuroscience 85:1253-1262.
65. Threlfell, S., M. A. Clements, T. Khodai, I. S. Pienaar, R. Exley, J. Wess, et al. 2010. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J. Neurosci. 30:3398-3408.
66. Ukai, M., T. Kobayashi, and T. Kameyama. 1994. Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine. Gen. Pharmacol. 25:433-438.
67. Vazquez, J., and H. A. Baghdoyan. 2001. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:R598-R601.
68. Volpicelli-Daley, L. A., A. Hrabovska, E. G. Duysen, S. M. Ferguson, R. D. Blakely, O. Lockridge, et al. 2003. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol. Pharmacol. 64:1309-1316.
69. Walker, J. M., S. W. Fowler, D. K. Miller, A. Y. Sun, G. A. Weisman, W. G. Wood, et al. 2011. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. Behav. Brain Res. 222:169-175.
70. Wess, J., R. M. Eglen, and D. Gautam. 2007. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat. Rev. Drug Discov. 6:721-733.
71. Woolf, N. J., and L. L. Butcher. 2011. Cholinergic systems mediate action from movement to higher consciousness. Behav. Brain Res. 221:488-498.
72. Xu, J., B. N. Cohen, Y. Zhu, G. Dziewczapolski, S. Panda, H. A. Lester, et al. 2011. Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the β2 nicotinic receptor. Mol. Psychiatry 16:1048-1061.
73. Yang, J. J., Y. T. Wang, P. C. Cheng, Y. J. Kuo, and R. C. Huang. 2010. Cholinergic modulation of neuronal excitability in the rat suprachiasmatic nucleus. J. Neurophysiol. 103:1397-1409.
74. Zhou, Q. Y., and R. D. Palmiter. 1995. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209.